Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dax, Dow, Bitcoin, Bushveld,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dax, Dow, Bitcoin, Bushveld,
We shall find out what’s in a name as Open Orphan (ORPH), a specialist contract research organisation announced that further to its announcement on 8 September 2022, the company’s change
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Pound/Dollar, Alkemy Capital Investments,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Pound / Dollar, Arrow
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Bushveld, DeepVerge, Galileo,
DeepVerge (DVRG) announced its audited financial results for the year ended 31 December 2021. The company said that for the third year running, DeepVerge has delivered “fantastic” triple digit percentage
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Angle, Arrow Exploration, Bushveld, Block, Cizzle,
Zak Mir takes a charting look at some of the most followed small caps. Today’s selection includes Arc, Angle, Audioboom, Bushveld, Bens, Clean, Eurasia, Golden, Galileo, Jersey, MySale, Pembridge, Uru.
Zak Mir takes a charting look at some of the most followed small caps on the London market. Today’s selection includes Bushveld, Bens, Evraz, Emmerson, Harvest, JKX, Kropz, McColl’s, Petropavlovsk,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection includes Aura, Bens, Borders, Bushveld, Bisichi, Calnex, Cloudbreak, Jersey,
OKYO Pharma (OKYO) a biopharmaceutical company, announced its interim results for the six months ended 30 September 2021. The company said that during the past six months its primary focus